Related Experiment Video
Updated: Mar 31, 2026

03:17
Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice
Published on: March 29, 2024
1.1K
Physical Activity Capture Technology With Potential for Incorporation Into Closed-Loop Control for Type 1 Diabetes
Vikash Dadlani1, James A Levine2, Shelly K McCrady-Spitzer1
1Endocrine Research Unit, Mayo Clinic, Rochester, MN, USA.
Journal of Diabetes Science and Technology
|October 21, 2015
Summary
Physical activity significantly impacts glucose variability in type 1 diabetes (T1D). Incorporating physical activity data into closed-loop control (CLC) systems shows promise for improved T1D management and patient outcomes.
Area of Science:
- Endocrinology
- Biomedical Engineering
- Exercise Physiology
Background:
- Physical activity is a key factor influencing glucose variability in type 1 diabetes (T1D).
- Closed-loop control (CLC) systems for T1D have begun incorporating physical activity as a non-glucose input.
- Current research is primarily based on small, single-center clinical trials.
Purpose of the Study:
- To review the current state of incorporating physical activity data into T1D management.
- To highlight the potential clinical benefits of physical activity tracking for T1D patients.
- To discuss the future direction of research and clinical trials in this area.
Main Methods:
- Review of existing literature and clinical trial registries.
- Analysis of the incorporation of physical activity into closed-loop control (CLC) protocols.
- Examination of the impact of physical activity on glucose variability and cardiovascular health.
Main Results:
- Limited studies exist, mostly small, single-center trials, with a maximum of 18 subjects.
- Physical activity data capture has potential benefits for cardiovascular fitness and weight management in T1D.
- A new 2-center prospective study is registered to build upon prior research.
Conclusions:
- Further research is needed to fully understand the role of physical activity in T1D management.
- Increased support for research, including grants from NIH, is expected.
- Future studies incorporating diverse physical activities and longer durations may inform device optimization for real-world CLC trials.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
1.4K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.4K
Carbohydrate Metabolism
15.0K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
15.0K
Diabetes Mellitus: Overview and Type I Subtype
6.0K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.0K

